Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Ricci

Showing results (151-160 of 284) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survivalValeria Sebastiani, Francesca Ricci, Belen Rubio-Viqueira, et al.
International Journal of Molecular Sciences|June 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian CarcinomasFederica Guffanti, Ilaria Mengoli, Francesca Ricci, et al.
Ultrastructural Pathology|April 25, 2007
Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placentaGianandrea Pasquinelli, Pierluigi Tazzari, Francesca Ricci, et al.
Toxins|February 23, 2013
Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cellsMaurizio Brigotti, Valentina Arfilli, Domenica Carnicelli, et al.
Thrombosis and Haemostasis|February 6, 2026
Shiga toxin 1a blunts Shiga toxin 2a-pathogenic effects in bloodElisa Varrone, Luciano Consagra, Giorgia Rossi, et al.
La Radiologia Medica|April 20, 2020
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomasMargarita Kirienko, Gaia Ninatti, Luca Cozzi, et al.
Respiratory Research|July 20, 2019
Tracing exogenous surfactant in vivo in rabbits by the natural variation of <sup>13</sup>CSonia Giambelluca, Francesca Ricci, Manuela Simonato, et al.
Oncoimmunology|September 14, 2020
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosisMartina Barone, Lucia Catani, Francesca Ricci, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemiaAlessandra Trojani, Marco Montillo, Michele Nichelatti, et al.
The Oncologist|February 12, 2015
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centersCarmelo Carlo-Stella, Francesca Ricci, Serena Dalto, et al.
Pageof 29

Showing results (151-160 of 284) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survivalValeria Sebastiani, Francesca Ricci, Belen Rubio-Viqueira, et al.
International Journal of Molecular Sciences|June 26, 2025
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian CarcinomasFederica Guffanti, Ilaria Mengoli, Francesca Ricci, et al.
Ultrastructural Pathology|April 25, 2007
Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placentaGianandrea Pasquinelli, Pierluigi Tazzari, Francesca Ricci, et al.
Toxins|February 23, 2013
Shiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cellsMaurizio Brigotti, Valentina Arfilli, Domenica Carnicelli, et al.
Thrombosis and Haemostasis|February 6, 2026
Shiga toxin 1a blunts Shiga toxin 2a-pathogenic effects in bloodElisa Varrone, Luciano Consagra, Giorgia Rossi, et al.
La Radiologia Medica|April 20, 2020
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomasMargarita Kirienko, Gaia Ninatti, Luca Cozzi, et al.
Respiratory Research|July 20, 2019
Tracing exogenous surfactant in vivo in rabbits by the natural variation of <sup>13</sup>CSonia Giambelluca, Francesca Ricci, Manuela Simonato, et al.
Oncoimmunology|September 14, 2020
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosisMartina Barone, Lucia Catani, Francesca Ricci, et al.
Cancer Biomarkers : Section a of Disease Markers|February 19, 2010
ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemiaAlessandra Trojani, Marco Montillo, Michele Nichelatti, et al.
The Oncologist|February 12, 2015
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centersCarmelo Carlo-Stella, Francesca Ricci, Serena Dalto, et al.
Pageof 29